# Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy

> **NCT07358130** · NA · RECRUITING · sponsor: **Kaohsiung Medical University** · enrollment: 552 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** vonoprazan, tripotassium dicitrate bismuthate, amoxicilline
- **DRUG:** rabeprazole, tripotassium dicitrate bismuthate, tetracycline, metronidazole

## Key facts

- **NCT ID:** NCT07358130
- **Lead sponsor:** Kaohsiung Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-21
- **Primary completion:** 2027-11-15
- **Final completion:** 2027-12-31
- **Target enrollment:** 552 (ESTIMATED)
- **Last updated:** 2026-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07358130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07358130, "Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT07358130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*